Top Ten Suppliers of Synthetic Biology Technology

Report Code: BIO119B

Publish Date: Feb 2024

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $5500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for synthetic biology is expected to increase from $35.5 billion in 2023 to $59.2 billion by the end of 2028, with a compound annual growth rate (CAGR) of 10.8% during the forecast period of 2023-2028.

Report Includes

  • 141 data tables and 33 additional tables
  • An overview of the top 10 suppliers of synthetic biology technology and the global market
  • Analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, forecasts for 2028, and projections of compound annual growth rates (CAGRs) through 2028
  • Evaluation of the current market size and revenue growth prospects specific to synthetic biology technology, accompanied by a market share analysis by test type, industry and geographic region
  • Coverage of evolving technologies, the current and future market potential, and the regulatory framework and reimbursement scenarios
  • Review of patents, the product pipeline and ESG trends related to the synthetic biology industry
  • Market share analysis of the key companies and coverage of mergers & acquisitions, joint ventures, collaborations, partnerships and other market strategies
  • Company profiles of major players within the industry, including Amyris Inc., Beyond Meat Inc., GenScript, Ginkgo Bioworks, Novozymes A/S, and Twist Biosciences.

Report Scope

The report is designed to be a comprehensive business tool to report focuses on 10 selected synthetic biology companies and the key areas in the field driving the industry growth that allows these companies to succeed.

The market is divided into segments and by application/industry as follows:

By product:

  • Enabling Products.
  • Biologic Components.
  • Integrated systems
  • Enabled Products.

 By Industry:

  • R&D Tools.
  • Diagnostics/Pharmaceuticals.
  • Agriculture.
  • Chemicals.
  • Energy.
  • Food & Beverages.
  • Others.

Each area is covered in detail, identifying current products in the market in the base year 2022, measuring current market size and identifying current and potential market drivers, forecasting for 2028, assessing current and potential competitors, and identifying current competitor market shares for the base year of 2022.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $31.5 billion
Market size forecast $59.2 billion
Growth rate CAGR of 10.8% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered Region, Product Type, Industry
Regions covered North America, Europe, Asia-Pacific, Latin America, Rest of the World (RoW)
Countries covered U.S., Mexico, Canada, Germany, France, U.K., Italy, Spain, Japan, China, India, Brazil, Argentina, Chile, Middle East, Africa, South America, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Sweden, Russia, Australia, New Zealand, Taiwan, Singapore, Malaysia, Thailand, Philippines, Indonesia
Key Market Drivers
  • Increasing Scope of Synthetic Biology in Healthcare Applications
  • Increasing Demand for Food Safety and Security
  • DNA Read, Write and Edit Technologies
  • Growing Role of Designer Organisms
  • Speeding up of Commercialization Pathways
  • Growth in Synthetic Biology Foundries
  • Increasing Research and Development Investment by Pharma Companies
Companies studied
TWIST BIOSCIENCETHERMO FISHER SCIENTIFIC INC.
NOVOZYMES A/SNOVARTIS AG
GINKGO BIOWORKSGILEAD SCIENCES INC.
GENSCRIPTCROPENERGIES AG
DSMAGILENT TECHNOLOGIES INC.
CODEXIS INC.AMYRIS INC.
BEYOND MEAT INC.VERBIO SE
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global top ten suppliers of synthetic biology technology market is projected to grow from $31.5 billion in 2022 to $59.2 billion in 2028 at a compound annual growth rate (CAGR) of 10.8% during the forecast period.
The growth of the synthetic biology market is driven by several factors, including a significant reduction in the cost of DNA sequencing and synthesis, enhancing the accessibility of these technologies, and fostering innovation. Governments and private investors in major countries such as U.S., China, U.K., India, and Japan are increasingly investing in synthetic biology, recognizing its potential to contribute to a sustainable bio-based economy. The evolution of advanced genome editing tools, notably CRISPR/Cas9, has empowered researchers with precise and efficient means to manipulate genetic material, fueling transformative applications drug and vaccine development. Synthetic biology has practical applications in the metabolic engineering of microorganisms, leading to the production of biofuels, flavors, fragrances, specialty chemicals, enzymes, and innovative food products such as plant-based and cultured meats. These advancements showcase the technology's potential to address challenges in manufacturing processes and contribute to diverse industries.
The top ten suppliers of synthetic biology technology is segmented based on the product type, by industry application and by geographic region.
The enabled products will dominate the market by the end of 2028.

Analyst Credentials

Gundreddy Gopinadh– Associate Consultant-Life Sciences Research
Gopinadh is an experienced professional with nearly nine years in the market research industry and experience in research and analysis, specializing in medical devices, pharmaceuticals, biotechnology, and in-vitro diagnostics verticals. He is an expert in handling custom projects by gathering data points, analyzing market trends, and ultimately providing clients with accurate market size numbers, actionable insights, and recommendations based on their unique business needs. Academically, Gopinadh holds a master’s degree in biotechnology from VIT University.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Top Ten Suppliers of Synthetic Biology Technology182Free
Chapter- 1: Introduction4Free
Chapter- 2: Summary and Highlights5Free
Chapter- 3: Market Overview3Free
Chapter- 4: Market Dynamics7Free
Chapter- 5: Emerging Trends/Technologies in the Synthetic Biology Market3Free
Chapter- 6: Sustainability in Synthetic Biology Market: An ESG Perspective9Free
Chapter- 7: Global Market of Synthetic Biology5Free
Chapter- 8: Market Breakdown by Product Type24Free
Chapter- 9: Market Breakdown by Industry48Free
Chapter- 10: Competitive Landscape7Free
Chapter- 11: Patents14Free
Chapter- 12: Company Profiles52Free
Chapter- 13: Appendix: Acronyms1Free
Published - Mar-2013| Analyst - Eric Mankin| Code - BIO119A

Report Highlights

Report Includes

  • Identification of the top 10 companies in the market for synthetic biology technology, and the rationale behind these selections.
  • Factors taken into account, including technical innovation, market leadership, and commitment to this market via investment in products.

When selecting these top 10 companies,  BCC Research looked across the industry spectrum and selected the most active and significant contributors while recognizing that there are many other contenders. Some of these “significant others” are  included but to a less detailed extent than the top 10 companies.

Related Reports

DNA Data Storage: Global Markets and Technologies

Published - Mar 2023 | Publisher - BCC Publishing | Code - BIO202B

The global DNA data storage market should reach $1.5 billion by 2027 from $105.5 million in 2022 at a compound annual growth rate (CAGR) of 69.8% for the forecast period of 2022 to 2027.

Synthetic Biology: Global Markets

Published - Mar 2022 | Publisher - BCC Publishing | Code - BIO066G

The global market for synthetic biology is estimated to increase from $9.5 billion in 2021 to $33.2 billion by 2026, at a compound annual growth rate (CAGR) of 28.4% during the forecast period of 2021-2026.

Global DNA Read, Write and Edit Market

Published - Oct 2019 | Publisher - John Bergin | Code - BIO193A

The global market for DNA read, write and edit applications should grow from $17.0 billion in 2019 to $43.1 billion by 2024 with a compound annual growth rate (CAGR) of 20.5% during the period of 2019-2024.

Recent Reports

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Top Ten Suppliers of Synthetic Biology Technology
Sample Report